XML 46 R34.htm IDEA: XBRL DOCUMENT
v3.25.4

Schedule II - Condensed Financial Information of Parent Company | 12 Months Ended
--- | ---
Dec. 31, 2025
Disclosure Text Block [Abstract] |
Condensed Financial Information of Parent Company Only Disclosure [Text Block] | Palomar Holdings, I nc. and Subsidiaries Balance Sheets (Parent Company) (In Thousands, except shares and par value data)
|  | December 31, 2025 |  |  | December 31, 2024 |
Assets |  |  |  |  |  |
Investments: |  |  |  |  |  |
Fixed maturity securities available for sale, at fair value (amortized cost: $160,793 in 2025, $153,425 in 2024) |  | $ | 159,707 |  |  | $ | 147,467 |
Equity securities, at fair value: (cost: $3,725 in 2025, $1,725 in 2024) |  |  | 5,415 |  |  |  | 2,182 |
Equity method investment |  |  | — |  |  |  | 2,277 |
Total investments |  |  | 165,122 |  |  |  | 151,926 |
Cash and cash equivalents |  |  | 2,136 |  |  |  | 1,797 |
Accrued investment income |  |  | 1,659 |  |  |  | 1,547 |
Prepaid expenses and other assets |  |  | — |  |  |  | — |
Receivables from subsidiaries |  |  | 84,561 |  |  |  | 78,961 |
Note receivable from subsidiary |  |  | 15,000 |  |  |  | 15,000 |
Deferred tax asset |  |  | 184 |  |  |  | — |
Investment in subsidiaries |  |  | 753,448 |  |  |  | 580,535 |
Total assets |  | $ | 1,022,110 |  |  | $ | 829,766 |
Liabilities and Stockholders’ equity |  |  |  |  |  |
Liabilities: |  |  |  |  |  |
Accounts payable and other liabilities |  | $ | 29,074 |  |  | $ | 12,396 |
Payables to subsidiaries |  |  | 50,370 |  |  |  | 88,340 |
Deferred tax liabilities |  |  | — |  |  |  | — |
Total liabilities |  |  | 79,444 |  |  |  | 100,736 |
Stockholders’ equity: |  |  |  |  |  |
Preferred stock, $0.0001 par value, 5,000,000 shares authorized as of December 31, 2025 and December 31, 2024, 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024 |  |  | — |  |  |  | — |
Common stock, $0.0001 par value, 500,000,000 shares authorized, 26,520,417 and 26,529,402 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively |  |  | 3 |  |  |  | 3 |
Additional paid‑in capital |  |  | 523,168 |  |  |  | 493,656 |
Accumulated other comprehensive income (loss) |  |  | (2,507 | ) |  |  | (26,845 | )
Retained earnings |  |  | 422,002 |  |  |  | 262,216 |
Total stockholders’ equity |  |  | 942,666 |  |  |  | 729,030 |
Total liabilities and stockholders’ equity |  | $ | 1,022,110 |  |  | $ | 829,766 |
See accompanying notes. Schedule II Palomar Holdings, Inc. and Subsidiaries Statements of Income (Parent Company) (In Thousands)
|  | Year Ended December 31, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Revenues: |  |  |  |  |  |  |  |  |
Net investment income |  | $ | 8,761 |  |  | $ | 4,877 |  |  | $ | 1,699 |
Net realized and unrealized gains (losses) on investments |  |  | 3,514 |  |  |  | 23 |  |  |  | (209 | )
Total revenues |  |  | 12,275 |  |  |  | 4,900 |  |  |  | 1,490 |
Expenses: |  |  |  |  |  |  |  |  |
Other operating expenses |  |  | 57,956 |  |  |  | 48,251 |  |  |  | 39,347 |
Loss before income taxes |  |  | (45,681 | ) |  |  | (43,351 | ) |  |  | (37,857 | )
Income tax benefit |  |  | (5,065 | ) |  |  | (10,199 | ) |  |  | (7,953 | )
Loss before equity in net income of subsidiaries |  |  | (40,616 | ) |  |  | (33,152 | ) |  |  | (29,904 | )
Equity in net income of subsidiaries |  |  | 237,686 |  |  |  | 150,725 |  |  |  | 109,105 |
Net income |  |  | 197,070 |  |  |  | 117,573 |  |  |  | 79,201 |
Other comprehensive income: |  |  |  |  |  |  |  |  |
Net unrealized losses on securities available for sale |  |  | (329 | ) |  |  | (5,114 | ) |  |  | (2,505 | )
Equity in other comprehensive income (loss) of subsidiaries, net of taxes |  |  | 24,668 |  |  |  | 2,261 |  |  |  | 15,029 |
Total comprehensive income |  | $ | 221,409 |  |  | $ | 114,720 |  |  | $ | 91,725 |
See accompanying notes. Schedule II Palomar Holdings, Inc. and Subsidiaries Statements of Cash Flows (Parent Company) (In Thousands)
|  | Year Ended December 31, |
|  | 2025 |  |  | 2024 |  |  | 2023 |
Operating activities |  |  |  |  |  |  |  |  |
Net income |  | $ | 197,070 |  |  | $ | 117,573 |  |  | $ | 79,201 |
Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |  |  |  |  |  |
Equity in undistributed earnings of subsidiaries |  |  | (237,686 | ) |  |  | (150,725 | ) |  |  | (109,105 | )
Stock-based compensation expense |  |  | 10,543 |  |  |  | 10,513 |  |  |  | 10,426 |
Net realized and unrealized (gains) losses on investments |  |  | (3,514 | ) |  |  | (23 | ) |  |  | 209 |
Amortization of premium on fixed maturity securities |  |  | 18 |  |  |  | 172 |  |  |  | 189 |
Deferred income tax expense (benefit) |  |  | 1,874 |  |  |  | (15,640 | ) |  |  | 2,787 |
Dividend received from subsidiary |  |  | 99,000 |  |  |  | 95,000 |  |  |  | — |
Changes in operating assets and liabilities: |  |  | (28,890 | ) |  |  | (80,154 | ) |  |  | 37,777 |
Net cash provided by (used in) operating activities |  |  | 38,415 |  |  |  | (23,284 | ) |  |  | 21,484 |
Investing activities |  |  |  |  |  |  |  |  |
Purchases of equity securities |  |  | (2,000 | ) |  |  | — |  |  |  | — |
Purchases of fixed maturity securities |  |  | (34,753 | ) |  |  | (114,611 | ) |  |  | (11,045 | )
Sales and maturities of fixed maturity securities |  |  | 27,124 |  |  |  | 13,004 |  |  |  | 9,232 |
Cash paid to subsidiaries |  |  | (109,150 | ) |  |  | — |  |  |  | — |
Cash received from subsidiaries |  |  | 109,489 |  |  |  | — |  |  |  | — |
Net cash used in investing activities |  |  | (9,290 | ) |  |  | (101,607 | ) |  |  | (1,813 | )
Financing activities |  |  |  |  |  |  |  |  |
Proceeds from stock offering, net of offering costs |  |  | (141 | ) |  |  | 115,724 |  |  |  | — |
Proceeds from common stock issued via equity incentive plans |  |  | 4,920 |  |  |  | 7,892 |  |  |  | 2,038 |
Policyholder contribution to surplus |  |  | 3,719 |  |  |  | 2,758 |  |  |  | 90 |
Repurchase of common stock |  |  | (37,284 | ) |  |  | — |  |  |  | (22,266 | )
Net cash (used in) provided by financing activities |  |  | (28,786 | ) |  |  | 126,374 |  |  |  | (20,138 | )
Net increase (decrease) in cash and cash equivalents |  |  | 339 |  |  |  | 1,483 |  |  |  | (467 | )
Cash and cash equivalents at beginning of period |  |  | 1,797 |  |  |  | 314 |  |  |  | 781 |
Cash and cash equivalents at end of period |  | $ | 2,136 |  |  | $ | 1,797 |  |  | $ | 314 |
Supplementary cash flow information: |  |  |  |  |  |  |  |  |
Cash paid for federal income taxes |  | $ | 57,961 |  |  | $ | 37,810 |  |  | $ | 20,640 |
Cash paid for state income taxes |  | $ | 1,124 |  |  | $ | 644 |  |  | $ | 484 |
Cash paid for interest |  | $ | 287 |  |  | $ | 1,048 |  |  | $ | 3,682 |
See accompanying notes. Schedule II 1.Accounting Policies Organization Palomar Holdings, Inc. (“the Company”), is an insurance holding company that domesticated in Delaware in March 2019. Prior to domestication in Delaware, the Company was known as GC Palomar Holdings (“GCPH”), which was a Cayman Islands incorporated insurance holding company formed on October 4, 2013 when GC Palomar Investor LP (“GCPI”) acquired control of GCPH. Basis of Presentation The accompanying condensed financial statements have been prepared using the equity method. Under the equity method, the investment in consolidated subsidiaries is stated at cost plus equity in undistributed earnings of consolidated subsidiaries since the date of acquisition. These condensed financial statements should be read in conjunction with the Company’s consolidated financial statements. Estimates and Assumptions Preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Those estimates are inherently subject to change, and actual results may ultimately differ from those estimates.

X
- Definition The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 Reference 4: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481231/810-10-45-11 + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration